Answers are grounded in this paper and cite their sources.
Reveals a rare link between anti-Hu neuropathy and colon cancer, suggesting the need for early evaluation.
Anti-Hu paraneoplastic neurological syndromes are most commonly associated with small-cell lung cancer and are rarely reported in colorectal malignancy. A 43-year-old man presented with progressive sensory neuropathy and weight loss. Evaluation revealed positive serum anti-Hu antibodies, markedly elevated cerebrospinal fluid protein, and imaging demonstrating an ascending colon mass. Right hemicolectomy confirmed Stage IIIA (pT3N1aM0) moderately differentiated adenocarcinoma, with mismatch repair–deficient (loss of MLH1 and PMS2) and B-Raf proto-oncogene, serine/threonine kinase wild-type tumor profile. Despite a significant family history, the patient had not undergone recommended early colorectal screening. Postoperative circulating tumor DNA was negative, and the patient was placed on active surveillance; however, neurological symptoms persisted, and immunomodulatory therapy access was initially limited. This case highlights a rare association between anti-Hu–associated myeloneuropathy and early-onset colon cancer and underscores the importance of malignancy evaluation in unexplained sensory neuronopathy.
No takes yet. Share an insight, caveat, or question.
Hussain et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: